Skip to main content
OpenTrials
Completed

NCT Number: NCT04564352

Hypolipidemic Effect of Adansonia Digitata

Adansonia digitata L. (AD) also known as Baobab is a huge tree that grows in many countries in sub-Saharan Africa. Many studies talking about AD biological activity including hypolipidemic, antioxidant and antimicrobials in animal's but not in human, This study will be undertaken to examine the effect of AD juice consumption against lipid profiles in traditional users and blood samples will be collected form participant's for investigated of lipid profiles pre and post AD juice drinking and the results will be compared.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Taibah University

Madinah, 42353, Saudi Arabia

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Tradition users (drink AD juice)

Exclusion criteria

  • Diabetes, hypertension, or chronic illness

Treatment and study plan

Adansonia digitata

Dietary Supplement

Juice of AD fruit

Other names: Baobab

Primary outcomes

  1. Decrease cholesterol level

    Time frame: 6 month's

    Hypolipidemias

Sponsors and collaborators

Lead sponsor

Taibah University

Other

Registry information

Official study title

Hypolipidemic, Antioxidant Activity of Adansonia Digitata Juice Consumption

Acronym: AD

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Sep 25, 2020
Registry last updated
Sep 25, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.